Brooks Laboratories Ltd
company logo

Brooks Laboratories Ltd

Brooks Lab. Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Start Investing in Brooks Laboratories Ltd

*By signing up you agree to our Terms and Conditions

Brooks Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Brooks Laboratories Ltd Fundamentals

349.08Cr

0

5.32

0.09

0

0%

24.99

i buttonClick here to know more about Fundamentals

Brooks Laboratories Ltd Financials

Brooks Laboratories Ltd Financialsright-arrow

Brooks Laboratories Ltd Shareholding Pattern

Brooks Laboratories Ltd Delivery and Volume

About Brooks Laboratories Ltd

Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The

-

2002

BROOKS

NameDesignation
Rajnish Kumar BediIndependent Director
Deepak MahajanIndependent Director
Sonia GuptaIndependent Director
Jitendra Pratap SinghWhole Time Director
Durga Sankar MaityWhole-time Director
Mr. Bhushan Singh RanaWhole-time Director
JAI PRAKASH VAIDYACompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Brooks Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Brooks Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Brooks Laboratories Ltd's share price is ₹132.61 as of 2024-10-30.
Brooks Laboratories Ltd's P/E ratio is - times as of 2024-10-30.
Brooks Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 5.32, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Brooks Laboratories Ltd's market capitalization is ₹349.08 Cr as on 2024-10-30.
The current financial records of Brooks Laboratories Ltd show a 1.9% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Brooks Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹31.05, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Brooks Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Brooks Laboratories Ltd's 52-week high and low as of 2024-10-30 are ₹132.66 and ₹125, respectively.